Sang Hoon Ahn

May 25, 2022
Impact of Expanding Hepatitis B Treatment Guidelines: A Modelling and Economic Impact Analysis
Summary Antiviral treatment in patients with chronic hepatitis B (CHB) may decrease the risk of hepatocellular carcinoma (HCC) and death. However, only 2.2% of CHB patients receive antiviral treatment globally. The complexity and strictness of the current clinical practice guidelines may limit expanding the treatment coverage for CHB. We examined the impact of expanding treatment […]

Read More
April 28, 2020
A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea
Summary Background and aims Hepatitis C virus (HCV) and its sequelae present a significant source of economic and societal burden. Introduction of highly effective curative therapies has made HCV elimination attainable. The study used a predictive model to assess the clinical and economic impact of implementing national screening and treatment policies toward HCV elimination in […]

Read More

English